Wilson Sonsini Goodrich & Rosati represented the investors in the transaction. D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
